Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Melanoma Research|December 3, 2002
Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastasesV Morvillo, I A Lüthy, A I Bravo, et al.Pigment Cell Research|June 1, 1995
Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IANC Kairiyama, I Slavutsky, I Larripa, et al.The International Journal of Biological Markers|July 1, 1994
Description of a new monoclonal antibody, FC-2.15, reactive with human breast cancer and other human neoplasiasJ Mordoh, S Leis, A I Bravo, et al.Nature Medicine|February 1, 1997
Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cellsM F Ledda, S Adris, A I Bravo, et al.Cancer|August 15, 1989
DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor-negative cellsC Ballare, A I Bravo, S Laucella, et al.Pigment Cell Research|June 1, 1995
Atypical androgen receptor in the human melanoma cell line IIB-MEL-JV Morvillo, I A Luthy, A I Bravo, et al.Cancer|March 1, 1991
The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancerC Ballare, A I Bravo, I Sorin, et al.Breast Cancer Research and Treatment|September 1, 1991
Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumorL Bover, M Barrio, I Slavutsky, et al.The Journal of Investigative Dermatology|March 1, 1995
Expression of cathepsin D in primary and metastatic human melanoma and dysplastic neviO L Podhajcer, L Bover, A I Bravo, et al.Cellular and Molecular Biology (Noisy-Le-Grand, France)|July 1, 1996
Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell modelM F Ledda, S Adris, A I Bravo, et al.Pageof 3